Cationic amino acid transporter PQLC2 is a potential therapeutic target in gastric cancer

Abstract

Tumor cells overexpress amino acid transporters to meet the increased demand for amino acids. PQ loop repeat‐containing (PQLC)2 is a cationic amino acid transporter that may be involved in cancer progression. Here, we show that upregulation of PQLC2 is critical to gastric cancer (GC) development in vitro and in vivo. PQLC2 mRNA and protein were overexpressed in GC tissues−especially of the diffuse type. PQLC2 overexpression promoted cell growth, anchorage independence and tumor formation in nude mice. This was due to activation of MEK/ERK1/2 and PI3K/AKT signaling. Conversely, PQLC2 knockdown caused growth arrest and cell death of cancer cells and suppressed tumor growth in a mouse xenograft model. These results suggest that targeting PQLC2 is an effective strategy for GC treatment.

This article is protected by copyright. All rights reserved.

http://bit.ly/2MTvOF1